Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Retail Industry News Latitude 27 Capital acquires jewelry components manufacturer JK Findings Latitude 27 Capital, a private investment firm, has acquired the assets of JK Jewelry, (doing business as JK… bySrinathMay 11, 2020
